Blogs

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SCYX

Forex

<p>NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) &#8212; WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SCYNEXIS, Inc. (NASDAQ: SCYX) between March 31, 2023 and September 22, 2023, both dates inclusive (the “Class Period”), of the important January 8, 2024 lead plaintiff deadline. SO WHAT: If you pu

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Projected to Reach US$ 45.51 Billion by 2034: Fact.MR Study

Forex

<p>The global increase in mental health awareness is creating a positive outlook for the ADHD therapeutics market. Rockville , Dec. 10, 2023 (GLOBE NEWSWIRE) &#8212; Expanding at 6.2% CAGR from 2024 to 2034, the global attention deficit hyperactivity disorder (ADHD) therapeutics market is estimated to reach a valuation of US$ 45.51 billio

ROSEN, A LONGSTANDING LAW FIRM, Encourages Generac Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GNRC

Forex

<p>NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Generac Holdings Inc. (NYSE: GNRC) between May 3, 2023 and August 3, 2023, both dates inclusive (the “Class Period”), of the important January 22, 2024 lead plaintiff deadline. SO WHAT: If […

MVST INVESTOR NOTICE: Robbins Geller Rudman &amp; Dowd LLP Announces that Microvast Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Forex

<p>SAN DIEGO, Dec. 10, 2023 (GLOBE NEWSWIRE) —  The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Microvast Holdings, Inc. (NASDAQ: MVST; MVSTW) securities between October 19, 2022 and November 20, 2023, both dates inclusive (the “Class Period”), have until February 5, 2024 to seek appointme

ACADIA SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) and Encourages Long-Term ACAD Investors to Contact the Firm

Forex

<p>PHILADELPHIA, Dec. 10, 2023 (GLOBE NEWSWIRE) &#8212; Kaskela Law LLC announces that it is investigating Acadia Pharmaceuticals Inc. (“Acadia”) (NASDAQ: ACAD) on behalf the company’s long-term investors. Recently an amended securities fraud complaint was filed against Acadia on behalf of certain investors who purchased shares of the Com

Page 1420 of 9786